가금류 진단 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of poultry diagnostics Market

The global poultry diagnostics market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.13 billion in 2026 to USD 3.31 billion by 2034, registering a strong CAGR of 14.31% during the forecast period (2026-2034).

North America dominated the market with a 53.02% share in 2025, supported by advanced veterinary infrastructure and strong biosecurity initiatives.

Poultry diagnostic tests are essential for disease surveillance and effective control of infectious poultry diseases such as avian influenza, Newcastle disease, infectious bronchitis, colibacillosis, mycoplasmosis, infectious bursal disease, and avian reovirus. Rising disease outbreaks and increasing global demand for poultry-derived products are driving the need for early and accurate diagnostic solutions.

Market Dynamics

Market Drivers

The rising prevalence of poultry diseases is a primary driver of market growth. Frequent outbreaks of avian influenza and other viral infections significantly increase the need for surveillance and testing. Government authorities worldwide are strengthening biosecurity frameworks and investing in disease monitoring programs to safeguard food security and poultry exports.

Additionally, the increasing global consumption of poultry meat and eggs has heightened awareness among farmers regarding flock health management. Governments and non-government organizations are implementing training programs and funding initiatives to promote disease prevention and early diagnosis.

Growing research and development activities by leading players, strategic partnerships, and product launches are further accelerating market expansion.

Market Restraints

Despite rapid growth, lack of awareness and limited access to veterinary healthcare in emerging regions restrain market penetration. In several low-income countries, poultry farmers lack proper knowledge about diagnostic services and vaccination programs.

Limited laboratory infrastructure, inadequate trained professionals, and lower adoption of biosecurity measures also restrict the use of advanced diagnostic technologies in rural areas.

Market Opportunities

The growing adoption of point-of-care (POC) diagnostic solutions presents significant opportunities. Rapid diagnostic kits provide quick results, affordability, portability, and ease of use, especially in remote poultry farms.

Collaborations between diagnostic companies, veterinary institutions, and agricultural authorities are creating growth opportunities. Increasing government funding for poultry health and biosecurity programs will further support market expansion through 2034.

Market Trends

Growing Preference for Point-of-Care Diagnostics

One of the most prominent trends in the poultry diagnostics market is the increasing shift toward point-of-care testing (POCT). Traditional laboratory methods such as RT-PCR and ELISA require skilled professionals and extended processing time. In contrast, rapid diagnostic kits offer immediate results and are highly suitable for field use.

Emerging markets are increasingly adopting these portable solutions due to cost-effectiveness and improved disease control efficiency. This trend is expected to significantly influence market growth during the forecast period.

Segmentation Analysis

By Product

The market is divided into instruments and consumables & kits.

The consumables & kits segment dominated with 78.78% market share in 2026, driven by rising usage of rapid diagnostic kits. These kits are affordable, portable, and widely accessible across rural settings.

The instruments segment is expected to grow steadily due to increasing laboratory-based testing in developed regions.

By Technology

Based on technology, the market includes ELISA, PCR, immunofluorescent assay, hemagglutination assay, and others.

• The ELISA segment dominated with 36.01% share in 2026, owing to its multiple applications and wide availability.
• PCR technology held the second-largest share, supported by its high sensitivity and ability to detect complex pathogens rapidly.

By Disease Indication

The market is categorized into avian influenza, infectious bursal disease, Newcastle disease, avian salmonellosis, mycoplasma, and others.

• Avian influenza dominated with 42.09% share in 2026, due to frequent outbreaks and mandatory surveillance.
• Infectious bursal disease held the second-largest share, driven by high infection rates in poultry-dense regions.

By End-User

The market includes veterinary diagnostic laboratories, veterinary hospitals & clinics, and others.

• Veterinary diagnostic laboratories led with 52.90% share in 2026, supported by well-established infrastructure in developed countries.
• Veterinary hospitals & clinics generated notable revenue, particularly in emerging economies.

Regional Insights

North America

North America led the market with USD 0.56 billion in 2025 and USD 0.60 billion in 2026. Strong government biosecurity investments and leading market players contribute to dominance.

Asia Pacific

Asia Pacific is projected to witness the highest CAGR through 2034, driven by expanding poultry farming and rising disease incidence. China, Japan, and India are key contributors.

Europe

Europe held a significant share due to strict animal welfare regulations and diagnostic advancements. Government initiatives to improve poultry health standards are supporting growth.

Latin America & Middle East & Africa

Latin America is expected to grow at the second-highest CAGR due to rising government funding. The Middle East & Africa region shows slower growth due to limited awareness and infrastructure gaps.

Competitive Landscape

Leading companies include IDEXX Laboratories, Inc., Zoetis Services LLC, Thermo Fisher Scientific Inc., GD, BioChek, BIONOTE, Vimian, and Innovative Diagnostics.

IDEXX Laboratories dominates the global market due to its strong product portfolio and global distribution network. Companies are focusing on strategic collaborations, new product launches, and expanding production capacity to strengthen market presence.

Conclusion

The global poultry diagnostics market is poised for significant growth, expanding from USD 1.05 billion in 2025 to USD 3.31 billion by 2034, at a robust CAGR of 14.31%. Rising disease outbreaks, increasing poultry consumption, and growing biosecurity initiatives are key growth drivers. While awareness gaps and infrastructure limitations pose challenges, the adoption of point-of-care diagnostics and strong government support will accelerate market expansion. North America will continue to dominate, while Asia Pacific is expected to emerge as the fastest-growing region during the forecast period.

Segmentation By Product

• Instruments
• Consumables & Kits

By Technology

• Enzyme-linked Immunosorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR)
• Immunofluorescent Assay
• Hemagglutination Assay
• Others

By Disease Indication

• Avian Salmonellosis
• Avian Influenza
• Newcastle Disease
• Mycoplasma
• Infectious Bursal Disease
• Others

By End-user

• Veterinary Hospitals & Clinics
• Veterinary Diagnostics Laboratories
• Others

By Region

• North America (By Product, By Technology, By Disease Indication, By End-user, By Country/ Sub-Region)
  • U.S.
  • Canada
• Europe (By Product, By Technology, By Disease Indication, By End-user, By Country/ Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, By Technology, By Disease Indication, By End-user, By Country/ Sub-Region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, By Technology, By Disease Indication, By End-user, By Country/ Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By Technology, By Disease Indication, By End-user, By Country/ Sub-Region)
  • GCC Countries
  • South Africa
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Poultry Diseases, By Key Countries/Regions
• 4.2. Key Industry Developments, By Key Players
• 4.3. Technological Advancements in Poultry Diagnostics Market
• 4.4. Impact of COVID-19 on Global Poultry Diagnostics Market

5. Global Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Instruments
  • 5.1.2. Consumables & Kits
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 5.2.2. Polymerase Chain Reaction (PCR)
  • 5.2.3. Immunofluorescent Assay
  • 5.2.4. Hemagglutination Assay
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 5.3.1. Avian Salmonellosis
  • 5.3.2. Avian Influenza
  • 5.3.3. Newcastle Disease
  • 5.3.4. Mycoplasma
  • 5.3.5. Infectious Bursal Disease
  • 5.3.6. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Veterinary Hospitals & Clinics
  • 5.4.2. Veterinary Diagnostics Laboratories
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Instruments
  • 6.1.2. Consumables & Kits
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 6.2.2. Polymerase Chain Reaction (PCR)
  • 6.2.3. Immunofluorescent Assay
  • 6.2.4. Hemagglutination Assay
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 6.3.1. Avian Salmonellosis
  • 6.3.2. Avian Influenza
  • 6.3.3. Newcastle Disease
  • 6.3.4. Mycoplasma
  • 6.3.5. Infectious Bursal Disease
  • 6.3.6. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Veterinary Hospitals & Clinics
  • 6.4.2. Veterinary Diagnostics Laboratories
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Instruments
  • 7.1.2. Consumables & Kits
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 7.2.2. Polymerase Chain Reaction (PCR)
  • 7.2.3. Immunofluorescent Assay
  • 7.2.4. Hemagglutination Assay
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 7.3.1. Avian Salmonellosis
  • 7.3.2. Avian Influenza
  • 7.3.3. Newcastle Disease
  • 7.3.4. Mycoplasma
  • 7.3.5. Infectious Bursal Disease
  • 7.3.6. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Veterinary Hospitals & Clinics
  • 7.4.2. Veterinary Diagnostics Laboratories
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. U.K
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Instruments
  • 8.1.2. Consumables & Kits
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 8.2.2. Polymerase Chain Reaction (PCR)
  • 8.2.3. Immunofluorescent Assay
  • 8.2.4. Hemagglutination Assay
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 8.3.1. Avian Salmonellosis
  • 8.3.2. Avian Influenza
  • 8.3.3. Newcastle Disease
  • 8.3.4. Mycoplasma
  • 8.3.5. Infectious Bursal Disease
  • 8.3.6. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Veterinary Hospitals & Clinics
  • 8.4.2. Veterinary Diagnostics Laboratories
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Instruments
  • 9.1.2. Consumables & Kits
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 9.2.2. Polymerase Chain Reaction (PCR)
  • 9.2.3. Immunofluorescent Assay
  • 9.2.4. Hemagglutination Assay
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 9.3.1. Avian Salmonellosis
  • 9.3.2. Avian Influenza
  • 9.3.3. Newcastle Disease
  • 9.3.4. Mycoplasma
  • 9.3.5. Infectious Bursal Disease
  • 9.3.6. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Veterinary Hospitals & Clinics
  • 9.4.2. Veterinary Diagnostics Laboratories
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Poultry Diagnostics Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Instruments
  • 10.1.2. Consumables & Kits
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 10.2.2. Polymerase Chain Reaction (PCR)
  • 10.2.3. Immunofluorescent Assay
  • 10.2.4. Hemagglutination Assay
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By Disease Indication
  • 10.3.1. Avian Salmonellosis
  • 10.3.2. Avian Influenza
  • 10.3.3. Newcastle Disease
  • 10.3.4. Mycoplasma
  • 10.3.5. Infectious Bursal Disease
  • 10.3.6. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Veterinary Hospitals & Clinics
  • 10.4.2. Veterinary Diagnostics Laboratories
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. IDEXX Laboratories, Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Zoetis Services LLC
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Vimian
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. GD
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. BioChek
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. BIONOTE
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Innovative Diagnostics
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. MEGACOR Diagnostik GmbH
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)